News
Mumbai-headquartered drugmaker Cipla Ltd is bolstering its focus on a pipeline of drugs to fight infections caused by ...
New research analyzing an online survey of 1,633 respondents found a 15% recent use of doxycycline post- and preāexposure ...
New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...
Ajay Sood addresses India's AMR challenges, emphasizing the need for stronger enforcement and innovative solutions at C-CAMP ...
Science Featured on MSN6h
Pandemic Pressure: How Azithromycin Use Shaped Resistance and Clonal Shifts in Staphylococcus aureusDuring the 2019 pandemic sweeping through hospitals, an insidious companion emerged in bloodstream infections, where bacteria ...
Pig Progress are publishing a special issue dedicated to the topic of antibiotic reduction. Published in October it will ...
New research analysing an online survey of 1,633 respondents found 15% recent use of doxycycline post- and pre-exposure prophylaxis (doxyPEP/PrEP ...
"The discovery was made in a West African parasite population during a study led by Dr. Abhinaya Venkatesan, a researcher at ...
13h
News-Medical.Net on MSNVaginal microbiome fights back against stubborn BV infectionsVaginal microbiome-drug interactions affect antibiotic treatment for bacterial vaginosis, emphasizing the need for ...
C-CAMP hosts India AMR Innovation Workshop to address antimicrobial resistance through One Health strategy and tech-driven ...
Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...
Rohit Kadam turns molecular research into scalable diagnostics that serve frontline clinics, not just publications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results